Top 5 Undervalued Stocks For 2019


Value investors get a bad rap. Sometimes, value investing is referred to as “cigar butt” investing, in that picking up cheap, undervalued stocks is equivalent to picking up mostly smoked cigars off of the sidewalk. A good friend and colleague of mine used to call me a “dumpster diver”. Guilty.

Why value? Personally, I hate overpaying. The old Wall Street maxim “buy low, sell high” is in direct conflict with “buy high, sell higher”. Typically, value stocks are less volatile than growth stocks. That doesn’t mean they’re less risky.


I’m not going to argue the outperformance of growth versus value. Sometimes growth outperforms. Sometimes value outperforms. I’m also not going to get lost in the weeds of grandfather of value investing Benjamin Graham’s notion of intrinsic value and margin of safety.

What I will do is point out three key indicators that will get the ball rolling in evaluating a value stock.

1. Forward P/E
I’ve found that the most useful metric used in determining a stock’s value is the price-to-earnings ratio (P/E). A stock’s P/E ratio measures its price relative to the underlying business’s earnings per share (EPS). The trailing P/E measures past earnings while the forward P/E is calculated with projected earnings. The forward P/E is my go-to valuation metric. A low forward P/E is an indicator of the marketplace’s confidence in the ability of the company to deliver on the earnings forecast. The lower the number, the less confident the market is, and thus the cheaper the stock.

Top 5 Undervalued Stocks For 2019: Natus Medical Incorporated(BABY)


Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Teradyne, Inc. (NYSE: TER) fell 10.8 percent to $37.02 in pre-market trading after the company issued downbeat Q2 guidance.
    Edwards Lifesciences Corporation (NYSE: EW) fell 9.2 percent to $122.29 in pre-market trading. Edwards Lifesciences reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter.
    New Gold Inc. (NYSE: NGD) fell 8.8 percent to $2.30 in pre-market trading after rising 4.13 percent on Tuesday.
    Gold Fields Limited (ADR) (NYSE: GFI) fell 8.6 percent to $3.61 in pre-market trading.
    Natus Medical Incorporated (NASDAQ: BABY) fell 8.2 percent to $32.95 in pre-market trading after the company issued weak forecast for the second quarter.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 7.9 percent to $3.50 in pre-market trading after climbing 27.09 percent on Tuesday.
    Bright Scholar Education Holdings Limited (NYSE: BEDU) shares fell 6.7 percent to $13.58 in pre-market trading after reporting Q1 results.
    Sangamo Therapeutics Inc (NASDAQ: SGMO) fell 5.9 percent to $16.75 in pre-market trading following announcement of a $200 million common stock offering.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares fell 5.7 percent to $3.29 in pre-market trading after declining 3.32 percent on Tuesday.
    Euronav NV (NYSE: EURN) fell 4.8 percent to $8.40 in pre-market trading.
    Limelight Networks, Inc. (NASDAQ: LLNW) shares fell 4.3 percent to $4.69 in pre-market trading.
    Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 4.1 percent to $32.92 in pre-market trading after the company issued downbeat quarterly results and reported the retirement of CFO William Clifford

  • [By Brian Orelli]

    Natus Medical (NASDAQ:BABY) is gearing up for a strong second half of the year, but the medical device maker’s investments in growth and integration of acquisitions have made for a weak start to the year.

  • [By Logan Wallace]

    Natus Medical (NASDAQ: BABY) and EnteroMedics (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Top 5 Undervalued Stocks For 2019: Electro Scientific Industries, Inc.(ESIO)


Advisors’ Opinion:

  • [By Shane Hupp]

    Electro Scientific Industries (NASDAQ: ESIO) and FuelCell Energy (NASDAQ:FCEL) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Electro Scientific Industries (ESIO)


    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    ValuEngine downgraded shares of Electro Scientific Industries (NASDAQ:ESIO) from a buy rating to a hold rating in a report issued on Friday morning.

Top 5 Undervalued Stocks For 2019: Espey Mfg. & Electronics Corp.(ESP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Espers (ESP) is a PoW/PoS coin that uses the HMQ1725 hashing algorithm. It was first traded on April 28th, 2016. Espers’ total supply is 21,802,827,290 coins. The Reddit community for Espers is /r/esperscoin and the currency’s Github account can be viewed here. Espers’ official Twitter account is @CryptoCoderz and its Facebook page is accessible here. Espers’ official website is espers.io.

  • [By Stephan Byrd]

    Espers (CURRENCY:ESP) traded up 5.2% against the US dollar during the one day period ending at 7:00 AM Eastern on May 28th. Espers has a market capitalization of $6.27 million and approximately $8,492.00 worth of Espers was traded on exchanges in the last 24 hours. One Espers coin can now be bought for about $0.0003 or 0.00000004 BTC on cryptocurrency exchanges including Livecoin and CoinExchange. During the last seven days, Espers has traded down 26.2% against the US dollar.

Top 5 Undervalued Stocks For 2019: U.S. Silica Holdings, Inc.(SLCA)


Advisors’ Opinion:

  • [By Joseph Griffin]

    U.S. Silica (NYSE:SLCA) had its price objective trimmed by Morgan Stanley from $47.00 to $43.00 in a report issued on Wednesday. The firm currently has a buy rating on the mining company’s stock.

  • [By Ethan Ryder]

    U.S. Silica (NYSE: SLCA) and Fairmount Santrol (NYSE:FMSA) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to

Top 5 Undervalued Stocks For 2019: ZIOPHARM Oncology Inc(ZIOP)


Advisors’ Opinion:

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

  • [By George Budwell]

    Shares of the clinical-stage biotech Ziopharm Oncology (NASDAQ:ZIOP) rose by a healthy 16% last month,according toS&P Global Market Intelligence. What sparked this sizable rally?

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Todd Campbell]

    After disclosing that the Food and Drug Administration is asking for more information before signing off on a phase 1 study of its “Sleeping Beauty” CAR-T for leukemia and lymphoma, shares in Ziopharm Oncology (NASDAQ:ZIOP) were tumbling 17.7% at 3 p.m. EDT today.

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *